The last years have brought us a tremendous success in the development of centrifugal and axial flow pumps. They are widely employed clinically as a simple, inexpensive and effective means to establish an acute support for the failing heart. On the basis of this success several groups are working towards developing an implantable chronic cardiac assist system. However, the clinical success of cardiac assist systems on the basis of pulsatile pumps is equally impressing. Nowadays there are patients with more than 600 days of functional time (Novacor). We are now focusing on the next step, cardiac assistance for an extended period of time, possibly encompassing the whole lifetime of the patient. The NIH has responded to the technical and clinical progress and recently has extended the required functional time of the device from two to five years. This increased level of demand raises the question of which concept a researcher in this field should pursue. Should he develop a centrifugal/axial bloodpump or should he investigate the principle of the pulsatile bloodpump?
It would be very useful to determine the potentials of both principles, if it is possible to identify the crucial issues related to these concepts.
There is a general agreement on the pro's and con's in the present discussion, summarized as follows:
Pro centrifugal pump
Small size down to 40 ml -simple design -one moving part -low fabrication cost achievable -simple energy conversion -high overall efficiency -low priming volumesmall residence time -no compliance chamber required.
Contra centrifugal pump
Thrombogenesis at the seal -nonpulsatile pump modehemodynamically unsafe when stopped -open shunt -mechanical blood trauma -high blood velocities-around 5 rn/s.
Pro pulsatile pump
Proven endurance for more than a year -long accumulated functional time -hemodynamically safe when stopped -mode-rate blood velocities-around 1 m/s -pulsatile pump mode.
Contra pulsatile pump
Considerable size, typical 500 ml complex designmany moving parts -complex energy conversion -difficult to achieve low fabrication cost -low overall efficiencyhigher priming volume -longer residence time of blood in pump compliance chamber mostly required.
The pro's for the centrifugal blood pump are obvious and require no further discussion.
Looking over the con's, it appears that the thrombogenesis at the seal can be argued with. There are various designs avoiding a seal altogether, firstly, by using a nutating or orbiting movement to transmit an angular momentum to the blood, secondly, by immersing the motor and its bearings into the bloodflow. Other designs do not even have bearings and hold the rotor with an electromagnetic suspension. The centrifugal blood pump delivers an even, nonpulsatile flow to the body. It has been discussed over decades whether this is acceptable for the body, but no general agreement has been reached. In my opinion these questions can also be dealt with, because functional times of over three months have been demonstrated succesfully in animal experiments.
At times it has been argued that the centrifugal pump is hemodynamically unsafe when stopped, because an open shunt is generated. As I see it, this poses no serious problem, since a stopped pulsatile pump is equally bad for the patient, even if it does not generate the shunt. Any cardiac assist system simply has to be designed not to fail.
I believe the mechanical blood trauma however to be a really serious issue. Up to this day the centrifugal bloodpumps generate a greater load on the blood.
The main physical reason for this is, that the blood velocities in a centrifugal bloodpump are not as low as in a pulsatile pump. The circumferential velocity in a centrifugal bloodpump is typically about 5 m/s at 5 Umin and at a pressure head of 100 mmHg. For physical reasons this velocity cannot be lowered significantly. Contrary to this a typical pulsatile pump has a blood velocity only 20% of this value, i.e. 1 m/s, This is a velocity which approximately = 0.43 = 0.24 = 0.1 Centrifugal pumps or pulsatile pumps equals that in the natural heart.
It has been argued that the high velocity in the centrifugal blood pump does not do a lot of damage, because the exposure time of the blood to the high shear stress is so short. This is because the blood passes through the pump so quickly whereas in a pulsatile bloodpump it remains for much longer.
The conclusion is that in the centrifugal bloodpump a very short exposure time is combined with a high shear rate and in the pulsatile bloodpump a longer exposure time is combined with a lower shear rate. There are experimental data which connect shear rate, exposure time and blood damage. However, these data apply only to a single pass of the blood through a shear field. In chronic application the blood passes through the pump roughly once every minute. As Copeland once said: "Mechanical pumping is a strong and permanent agression against the blood." (1) Comparison of both pumping principles using these data reveals neither to be superior to the other.
Another criteria has to be considered, which concerns the difference in the kind of kinetic energy which the pump releases into the blood. The typical centrifugal blood pump disperses a much higher amount of energy into the blood than the typical pulsatile bloodpurnp'', This can be illustrated by a comparison of three types of assist devices, all are assumed to be electrically driven and designed for long term use.
An assist device with an electric motor and a centrifugal or axial boodpump.
An assist device with an electric motor, a mechanical gear and a pulsatile boodpump.
An assist device with an electric motor, a electrohydraulic energy converter and a pulsatile boodpump.
It is further assumed, that these pumps have a design point defined by the flow of 5 L/min against a pressure head of 100 mmHg. This is equivalent to a hemodynamic power of 1.13 Watts.
The efficiencies of the components are estimated to:
In the specialized literature higher efficiencies for centrifugal pumps are reported. The peak efficiency however usually has a narrow flow range, which will hardly ever be encountered in the ever changing flow conditions in the body. The estimated 11 centrifugal bloodpump = 0.4 seems realistic.
The efficiency of the pulsatile bloodpump calls for an explanation: It is computed from the kinetic energy brought into the blood by the valves. This energy can be precisely measured (2) Figure 1 shows a diagram of energy losses in the different assist devices.
The assist device with an electric motor, a mechanical gear and a pulsatile bloodpump has the smallest loss. It needs only 2.6 Watts input energy. Next follows the assist device with an electric motor and a centrifugal or axial boodpump. This requires 4.7 Watts. More energy is required by the assist device with an electric motor, an electrohydraulic energy converter and a pulsatile boodpump, which uses 10.6 Watts. All this energy goes into the blood and is carried away and dissipated by the body.
However, the state of the energy, upon entering the blood is very different from device to device: it is partly thermal energy and another part of it is kinetic energy. Thermal energy is known to be harmless, while kinetic energy is not. Energy in the form of a turbulent jet is harmful, when in the presence of a foreign material. This foreign material is the pump itself.
The diagram shows that the centrifugal bloodpump dissipates about ten times as much kinetic energy as a pulsatile pump.
The dissipation of 1.7 Watts by the centrifugal bloodpump is equivalent to the kinetic energy dissipation of a flow of 5 Umin through an aortic stenosis which generates a pressure drop of 150 mmHg. One might argue, that such a stenosis has a remarkably small damaging effect on the blood. However, this is only true of a stenosis found in patients. Their vessel wall may be pathologically altered, but it remains a natural wall. The centrifugal bloodpump constitutes a foreign material which damages blood in
